— Know what they know.
Not Investment Advice
Also trades as: 0J8P.L (LSE) · $vol 1M

IDXX NASDAQ

IDEXX Laboratories, Inc.
1W: -1.4% 1M: +0.2% 3M: -1.7% YTD: -17.0% 1Y: +1.1% 3Y: +2.5% 5Y: -16.9%
$569.54
+13.34 (+2.40%)
 
Weekly Expected Move ±4.8%
$492 $518 $544 $571 $597
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Neutral · Power 63 · $44.9B mcap · 79M float · 0.830% daily turnover · Short 34% of daily vol
Smart Money Score
Moderate 50
Insider
Congress1 trades
ETF Holdings
Key Statistics
Market Cap$44.9B
52W Range518.55-769.98
Volume433,670
Avg Volume652,327
Beta1.55
Dividend
Analyst Ratings
13 Buy 8 Hold 1 Sell
Consensus Buy
Company Info
CEOMichael Erickson
Employees11,000
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1991-06-21
Websiteidexx.com
One IDEXX Drive
Westbrook, ME 04092
US
207 556 0300
About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Recent Insider Trades

NameTypeSharesPriceDate
FENNELL GEORGE M-Exempt 639 2026-06-01
FENNELL GEORGE M-Exempt 639 2026-06-01
FENNELL GEORGE F-InKind 284 $566.79 2026-06-01
Vandebroek Sophie V. A-Award 525 $533.92 2026-05-12
Vandebroek Sophie V. A-Award 234 2026-05-12

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms